Back to articles
Comparative guide · 6 min read

Holy basil (Tulsi) vs Ashwagandha — adaptogens for stress, compared

Updated 2026-05-15 · Reviewed by SupplementScore editors · No sponsorships

Holy basil (Ocimum sanctum / O. tenuiflorum, "Tulsi") and ashwagandha (Withania somnifera) are the two most-prescribed adaptogens in classical Ayurveda and the two consumers most often weigh between in a Western "stress" context. They overlap on subjective stress reduction. They diverge on dose, thyroid effects, glycaemic effects, and the strength of the underlying trial portfolio. The honest read: ashwagandha has more trial data; holy basil has a more benign side-effect profile in users with thyroid concerns.

Quick verdict

GoalBetter choiceWhy
Subjective stress / perceived-stress-scale reductionAshwagandhaLarger trial portfolio; PSS reductions of 30–45% in multiple RCTs at 300–600 mg KSM-66.
Cortisol modulationAshwagandhaSeveral trials show ~14–28% reductions in serum cortisol; holy basil data thinner.
Glycaemic control / fasting glucoseHoly basilMultiple small RCTs show holy basil modestly lowers fasting glucose; ashwagandha is closer to neutral.
User has subclinical hypothyroid / Hashimoto's concernsHoly basilAshwagandha modestly raises T4; holy basil does not have a comparable thyroid-stimulating signal.
Anxiety / sleep onsetAshwagandhaBetter trial evidence for subjective sleep latency and quality.
Safety in long-term daily useHoly basil (mild edge)Both reasonably safe; holy basil has rare hepatotoxicity reports at very high doses; ashwagandha has post-market liver injury case reports plus thyroid effects.

How they actually work

Ashwagandha — the better-evidenced adaptogen

Ashwagandha root extracts (the marketed forms — KSM-66 from Ixoreal, Sensoril from Nutragenesis, Shoden from Arjuna) are standardised to withanolide content. The mechanism stack: HPA-axis modulation (reduces evening cortisol most consistently), GABAergic activity at withanoside-mediated receptors, mild thyroid-stimulating effect (T4 rises ~14% in trials), and possible serotonergic modulation. The subjective-stress trial portfolio is the largest of any adaptogen — 15+ RCTs with consistent direction. Anxiolytic effect emerges around weeks 4–8 of daily dosing.

Holy basil — the polyphenol-rich Tulsi

Holy basil contains eugenol, ursolic acid, rosmarinic acid, and ocimumosides. The mechanism stack: COX-2 inhibition, mild glycaemic effect via partial restoration of pancreatic beta-cell function, and HPA-axis modulation through a different route than ashwagandha (less cortisol-specific, more anti-inflammatory). Six RCTs (Jamshidi/Cohen 2017 systematic review) suggest perceived-stress reductions; the trials are smaller than the ashwagandha portfolio.

Stress and anxiety — ashwagandha by a length

For someone presenting with chronic, daily stress and elevated perceived-stress-scale scores, ashwagandha has the larger and more consistent evidence base. Holy basil's stress trials are smaller and less standardised. Both work over 4–8 weeks rather than acutely.

Glycaemic and lipid effects — holy basil's modest niche

Holy basil at 500–2500 mg/day has shown 7–15% fasting glucose reductions in small RCTs, alongside small HbA1c improvements. It is not a substitute for metformin or other glycaemic therapies, but it is a reasonable adjunct in users wanting an Ayurvedic add-on for prediabetes or metabolic syndrome. Ashwagandha's glycaemic data are weaker.

Thyroid — the key differentiator

Ashwagandha raises T4 modestly in users with subclinical hypothyroidism (Sharma 2018: T4 +14%, TSH -17%). This is desirable in subclinical hypo, but is a problem in users with Graves', subclinical hyperthyroidism, autoimmune thyroid disease, or anyone on levothyroxine (it can require dose adjustment). Holy basil does not have a comparable thyroid-stimulating signal. If thyroid is in play, holy basil is the safer adaptogen choice.

Practical rule. If you have stress and no thyroid concerns: ashwagandha 300–600 mg KSM-66/day for 6–12 weeks has the most evidence. If you have Hashimoto's, Graves', subclinical hyper, are on levothyroxine, or have a strong thyroid-family history: holy basil 500–1000 mg/day is the safer adaptogen with overlapping stress benefits. Either way, time-limit the trial and reassess — adaptogens are not lifelong vitamins.

Dose, form, and timing

Ashwagandha: 300–600 mg KSM-66 (root extract, 5% withanolides) once daily with breakfast or 300 mg b.i.d. Sensoril (root + leaf, 10% withanolides) at 250 mg/day is a more concentrated alternative. Shoden at 60–120 mg/day if higher withanolide concentration is preferred. 6–12 week trial; deload if used long-term.

Holy basil: 500–1000 mg/day of leaf extract (or 2500 mg of dried leaf). Some products combine with rosmarinic-acid-standardised extracts. Take with or without food.

Safety

Ashwagandha: Thyroid effect (caution in autoimmune thyroid disease and on levothyroxine). Rare hepatotoxicity case reports in long-term users — discontinue if liver labs rise unexplained. Caution in pregnancy (historical use as abortifacient). Caution with sedative or immunosuppressive medications. Possible interaction with thyroid hormone — monitor TSH if used >3 months.

Holy basil: Mild antiplatelet effect — caution with anticoagulants. Hypoglycaemic effect — monitor in users on diabetes medications. Very high doses or extended use have rare hepatotoxicity reports. Pregnancy/lactation: limited safety data, traditional advice is to avoid.

Who should pick each

Pick ashwagandha if: chronic stress is the dominant complaint, no thyroid issues, not on levothyroxine, not pregnant or trying to conceive.

Pick holy basil if: thyroid concerns are present, prediabetes/metabolic syndrome is co-occurring, or you tolerated ashwagandha poorly (anecdotal "flattening" reports are more common with ashwagandha than holy basil).

What we'd actually take

Default: ashwagandha KSM-66 300 mg b.i.d. for 6–8 weeks, reassess. If thyroid is in play or there are concerns about ashwagandha's flat-affect reports: holy basil 500 mg b.i.d. with food for 8–12 weeks. Sleep hygiene, exercise, and CBT-I remain higher-impact than any adaptogen.

Sources

Read more: